Normal mesenteric lymph blunts the pulmonary inflammatory response to endotoxin

Aaron M Cheng1, Ernest E Moore, Tomohiko Masuno

  • 1Department of Surgery, Denver Health Medical Center, University of Colorado Health Sciences Center, Denver, Colorado 80204, USA.

Abstract

Insights

Normal mesenteric lymph (NML) protects against lung inflammation by decreasing ICAM-1 expression. This protective effect is lost in post-shock mesenteric lymph (PSML) due to decreased lipoproteins after hemorrhagic shock.

Area of Science:

  • Endocrinology
  • Immunology
  • Pathophysiology

Background:

  • Hemorrhagic shock (HS) can lead to acute lung injury (ALI).
  • Mesenteric lymph is a potential mediator linking gut ischemia and ALI post-HS.
  • Focus has been on toxic mediators in post-shock mesenteric lymph (PSML), but loss of protective mediators in normal mesenteric lymph (NML) is also possible.

Purpose of the Study:

  • To investigate the protective role of NML against inflammatory insults to pulmonary endothelium.
  • To determine if this protective effect is diminished in PSML.
  • To identify the components within NML responsible for this protective effect.

Main Methods:

  • Primary human pulmonary endothelial cells (HMVECs) were incubated with NML or PSML from rats subjected to HS and resuscitation.
  • Cells were stimulated with lipopolysaccharide (LPS) to induce inflammation.
  • ICAM-1 surface expression was measured by flow cytometry.
  • Lipoproteins were extracted from NML to assess their role in the protective effect.

Main Results:

  • NML significantly decreased LPS-induced ICAM-1 expression on HMVECs by 71% compared to controls.
  • PSML did not show this protective effect, with significantly higher ICAM-1 expression than NML.
  • Extraction of lipoproteins from NML abolished its protective effect against LPS-induced ICAM-1 expression.

Conclusions:

  • Lipoproteins in NML possess anti-inflammatory properties that reduce LPS-induced ICAM-1 expression in pulmonary endothelium.
  • A reduction in these protective lipoproteins in mesenteric lymph following HS and resuscitation may contribute to PSML-induced lung injury.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...